G1 Therapeutics, Inc.

The current price of GTHX is 4.11 USD — it has decreased by 1.56% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange G1 Therapeutics, Inc. stocks are traded under the ticker GTHX.

G1 Therapeutics, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.

GTHX stock is 8.58% volatile and has beta coefficient of 1.90. Check out the list of the most volatile stocks — is G1 Therapeutics, Inc. there?

One year price forecast for G1 Therapeutics, Inc. has a max estimate of 12.00 USD and a min estimate of 5.00 USD.

GTHX earnings for the last quarter are −0.35 USD per share, whereas the estimation was −0.34 USD resulting in a −2.74% surprise. The estimated earnings for the next quarter are −0.28 USD per share. See more details about G1 Therapeutics, Inc. earnings.

G1 Therapeutics, Inc. revenue for the last quarter amounts to ‪12.30 M‬ USD despite the estimated figure of ‪14.24 M‬ USD. In the next quarter revenue is expected to reach ‪13.08 M‬ USD.

Yes, you can track G1 Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

GTHX net income for the last quarter is ‪−10.88 M‬ USD, while the quarter before that showed ‪−18.20 M‬ USD of net income which accounts for 40.24% change. Track more G1 Therapeutics, Inc. financial stats to get the full picture.

Today G1 Therapeutics, Inc. has the market capitalization of ‪217.67 M‬, it has increased by 3.70% over the last week.

No, GTHX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, GTHX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade G1 Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

GTHX reached its all-time high on Sep 11, 2018 with the price of 69.57 USD, and its all-time low was 1.08 USD and was reached on Oct 9, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 100.00 employees. See our rating of the largest employees — is G1 Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So G1 Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating G1 Therapeutics, Inc. stock shows the sell signal. See more of G1 Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on G1 Therapeutics, Inc. future price: according to them, GTHX price has a max estimate of 12.00 USD and a min estimate of 5.00 USD. Read a more detailed G1 Therapeutics, Inc. forecast: see what analysts think of G1 Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. G1 Therapeutics, Inc. EBITDA is ‪−39.01 M‬ USD, and current EBITDA margin is −47.28%. See more stats in G1 Therapeutics, Inc. financial statements.